Temple University Joins Nationwide Network of Universities to Transform How Medications and Vaccines are Delivered in US from 2022 – 2031

October 14, 2021
Press Contact: Katie Battista, 215-707-7652, bat@temple.edu
Academic Contact: Van Hellerslia, PharmD, 215-707-1290, van.hellerslia@temple.edu

 

Philadelphia, PA – Today, Temple University announced that it is joining the RAPID Alliance Medications 360 Study, with a goal of transforming how medications and vaccines are delivered in the US from 2022 – 2031. The RAPID Alliance is a multi-stakeholder research consortium founded in the University of Louisville Center for Health Organization Transformation (CHOT), a National Science Foundation-funded research center. 

Temple University will help lead an all-hands-on-deck effort to co-create the RAPID Alliance Medications 360 Framework 2022-2031, a set of transformational strategies and a nationally prioritized research agenda for optimizing the use of medications, vaccinations and other therapies from 2022-2031. 

This project is building on a 2020 research study, conducted by UofL researchers during the COVID-19 pandemic, that identified strategic opportunities to improve health and wellbeing for tens of millions of people while reducing US spending on likely-avoidable hospitalizations, emergency department and doctor visits by as much as $528 billion dollars.

Temple University School of Pharmacy will contribute to this effort by supporting research and action in areas including state-level strategies for Pennsylvania. In addition, Temple University will help support special study sections on Immigrant Health. 

Van Hellerslia, PharmD, Clinical Associate Professor, who is helping lead this project for Temple University, said: “We are excited to be part of this important national effort to co-create new, actionable strategies and research priorities to optimize medication and vaccine use for US populations with a particular interest in Immigrant Health.”

Universities participating in the RAPID Alliance and its Medications 360 Study include American University of Health Sciences, Belmont University, Binghamton University, California Northstate University, Chapman University, Ferris State University, Howard University, Lipscomb University, Loma Linda University, Long Island University, Marshall University, Medical College of Wisconsin, Mercer University, North Dakota State University, Oregon Health & Science University, Oregon State University, South Dakota State University, Sullivan University, Temple University, University of Arkansas for Medical Sciences, University of Cincinnati, University of Colorado, University of Georgia, University of Hawaii Hilo, University of Houston, University of Kentucky, University of Louisville, University of Michigan, University of Mississippi, University of Nebraska Medical Center, University of Nevada Reno, University of Pittsburgh, University of Rhode Island, University of South Carolina, University of Tennessee Health Science Center, Washington State University, Wayne State University, and Western University of Health Sciences.  

Lucinda Maine, Chief Executive Officer of the American Association of Colleges of Pharmacy (AACP), a founding member of the RAPID Alliance Practice Council, said: 

“We are delighted to see this multi-university research consortium developing. We believe national and state strategies driven by research are key to optimizing medication use for US populations in the next decade.”  

The consortium plans to add up to 30 additional universities in the coming months to support the effort.  

Want to join the strategic planning effort? Leading healthcare companies, associations, government agencies, foundations, technology providers and other stakeholders at national and state levels are invited and encouraged to have 1 or more strategic leaders participate in the strategic planning process.  

Learn more, or join the study, at meds360.starstudy.link.  

###

The Temple University School of Pharmacy, established in 1901, carries more than a century’s worth of history and reliability in pharmacy education. Our programs, assets, and products support our ongoing success in creating opportunities to transform lives. The school provides opportunities to earn degrees in pharmacy, pharmaceutical sciences, and regulatory affairs and quality assurance and lead innovations in pharmacy practice and science. We promote and preserve pharmacy and pharmacy-related professions by delivering excellence and opportunity through education, scholarship, research, and practice.

The National Science Foundation Center for Health Organization Transformation (NSF-CHOT) at the University of Louisville is a federally awarded industry-university collaborative research center that aims to accelerate applied research and workforce development by integrating health care systems engineering, health services research and health policy. For more information visit louisville.edu/sphis/departments/chot

The RAPID Alliance is a research consortium in NSF-CHOT and the Frazier Polypharmacy Program at UofL. Founding members include leaders from the Patient Advocate Foundation (PAF), American Pharmacists Association (APhA), American Society of Health-System Pharmacists (ASHP), Academy of Managed Care Pharmacy (AMCP), American Society of Consultant Pharmacists (ASCP), American Association of Colleges of Pharmacy (AACP), National Alliance of State Pharmacy Associations (NASPA), National Association of Chain Drug Stores (NACDS), National Community Pharmacies Association (NCPA), the Community Pharmacy Foundation, CPESN USA, Sanofi and Sanofi Pasteur, a leading researchers from multiple schools of pharmacy and health science centers. For more information visit rapidalliance.org.